Licheng Zhang

A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer

Andrew W. Chung, Kartik Anand, Ann C. Anselme et al. · Science Translational Medicine · 2021 · 109 citations

Medicine, Oncology, Pharmacology +10

Potentiating Antitumor Efficacy Through Radiation and Sustained Intratumoral Delivery of Anti-CD40 and Anti-PDL1

Hsuan‐Chen Liu, Dixita Viswanath, Federica Pesaresi et al. · International Journal of Radiation Oncology*Biology*Physics · 2020 · 70 citations · Full text

Medicine, Oncology, Radiation Oncology +14

Integrative analysis of genomic and epigenomic regulation reveals miRNA mediated tumor heterogeneity and immune evasion in lower grade glioma

Zhen Yang, Xiaocen Liu, Hao Xu et al. · Communications Biology · 2024 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +17

A Phase 2 Trial of Enhancing Immune Checkpoint Blockade by Stereotactic Radiation and <i>In Situ</i> Virus Gene Therapy in Metastatic Triple-Negative Breast Cancer

Kai Sun, Yitian Xu, Licheng Zhang et al. · Clinical Cancer Research · 2022 · 37 citations · Full text

Medicine, Oncology, Radiation Oncology +17

<i>Retracted</i>: EphB3‐targeted regulation of miR‐149 in the migration and invasion of human colonic carcinoma <scp>HCT</scp>116 and <scp>SW</scp>620 cells

Guodong Zhang, Xiaozhu Liu, Yinfeng Li et al. · Cancer Science · 2017 · 20 citations · Full text

Medicine, Cancer Biology, Oncology +17